Prevalence of metabolic syndrome and its association with atrial arrhythmias in patients with implanted permanent pacemaker for cardiac conduction abnormality

Indian Heart J. 2023 Nov-Dec;75(6):462-464. doi: 10.1016/j.ihj.2023.10.006. Epub 2023 Oct 31.

Abstract

The objective of the study was to find the prevalence of metabolic syndrome along with identifying the atrial arrhythmias, QTC interval, and coronary artery disease among these patients during follow-ups. Among 171 subjects who were implanted with permanent pacemakers, metabolic syndrome was present in 90 (52.6 %). Prevalence of Arrhythmias was 49 (28.7 %), atrial tachycardia (AT)/atrial fibrillation (AF) was seen in 29 (17 %) patients. Our study showed that there is a strong association between metabolic syndrome and atrial arrhythmias. Metabolic syndrome, age, coronary artery disease and Systolic blood pressure were good independent predictors of atrial arrhythmias among patients with pacemaker implantation.

Keywords: Atrial arrhythmia; Metabolic syndrome; Permanent pacemaker implants.

MeSH terms

  • Atrial Fibrillation* / epidemiology
  • Atrial Fibrillation* / therapy
  • Coronary Artery Disease*
  • Humans
  • Metabolic Syndrome* / complications
  • Metabolic Syndrome* / epidemiology
  • Pacemaker, Artificial* / adverse effects
  • Prevalence